Current filters:  
USA
Healthcare
Food and Drugs Law
United States
Kelley Drye & Warren LLP
The FTC warned that the claims do not appear to be supported by competent and reliable scientific evidence, in violation of the FTC Act.
Alston & Bird
This week, the Biden Administration issued new COVID-19 vaccination requirements and HHS announced an additional $25.5 billion to support U.S. providers.
Perkins Coie LLP
The Federal Circuit's August 5, 2021 ruling in GlaxoSmithKline LLC v. Teva Pharm. USA, Inc. (link to issued opinion), is an important development in the law of "skinny"...
Mintz
It's finally here – the Drug Pricing Plan that President Biden ordered the Department of Health and Human Services (HHS) to produce by the end of August (the "Plan")...
Buchanan Ingersoll & Rooney PC
The President released a six-pronged, national strategy plan aimed at combatting COVID-19 by implementing vaccination requirements, while also keeping schools open and safe...
Shipman & Goodwin LLP
Shipman is pleased to share with our Connecticut friends and clients the following summary of relevant legislative developments.
Foley & Lardner
Many companies need strong supply chain traceability. For the most prevalent tracing challenges, blockchain may provide a formidable solution.
Akin Gump Strauss Hauer & Feld LLP
As has been widely reported, earlier this summer, President Biden issued Executive Order (EO) 14036, "Promoting Competition in the American Economy."
Frankfurt Kurnit Klein & Selz
The Federal Trade Commission and the U.S. Food and Drug Administration sent cease and desist letters to ten companies, telling them to stop making unsubstantiated claims that their products treat or cure diabetes.
Foley Hoag LLP
Comments obtained on the ANPR are intended to inform future rulemaking by FSIS on labeling requirements to prevent misbranding.
Winston & Strawn LLP
The patentee sued the alleged infringer over a generic version of the pharmaceutical drug Coreg® (carvedilol). Coreg® was approved by the FDA for three indications...
Alston & Bird
A purchaser of Cracker Barrel brand cheese bites with "butter crackers" has brought a putative class action alleging that the company's claim of "butter" crackers is misleading because the fat used in the crackers is actually oil ...
Winston & Strawn LLP
The urgency of the crisis has forced policymakers and regulators to rethink long-established practices and develop innovative solutions.
Husch Blackwell LLP
On August 23rd the U.S. Court of Appeals for the Federal Circuit ("Federal Circuit") struck down federal regulations restricting refunds on export taxes and restricting beer and wine manufacturers...
Ogletree, Deakins, Nash, Smoak & Stewart
As we previously reported, on February 22, 2021, Governor Phil Murphy signed into law the New Jersey Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization Act (CREAMMA)...
Seyfarth Shaw LLP
The ACA requires "transparency in coverage" cost-sharing disclosures by most health plans. In November of 2020, the Departments issued Final Transparency in Coverage Rules...
Mayer Brown
Starting October 1, the Centers for Disease Control and Prevention (CDC) will require applicants for a US green card
Manatt, Phelps & Phillips LLP
The Biden Administration this month significantly relaxed several compliance obligations related to price transparency and surprise billing that have been of intense concern...
Taft Stettinius & Hollister
A $235 million verdict is an eye popping number that will force all generic companies to be more careful on launching at-risk with a skinny label.
Arnold & Porter
After a public consultation last July, the EMA published its Reflection Paper on Good Manufacturing Practice (GMP) and Marketing Authorisation Holders (MAH) on 23 July 2021.
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Popular Contributors
Upcoming Events
Mondaq Social Media